LCA-0061

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameLCA-0061
Drug Alias NameLCA-0061
ClassificationBiologics > Lysosome-Targeting Chimaeras (LYTAC)
Mechanisms of ActionImmunoglobulin E degraders
TargetsImmunoglobulin E
Therapy Area/IndicationsAllergic asthmaFood HypersensitivityHypersensitivity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLycia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLycia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAllergic asthmaFood HypersensitivityHypersensitivity +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A